Skip to main content

Asia Weekly: Trump targets pharma, chips and India

Malaysia and Taiwan are the two countries in Asia most exposed to Trump’s threatened 100% tariffs on semiconductors. However, exemptions for companies with production facilities in the US and limited US chip capacity should ease the overall impact. Singapore is the most vulnerable country to higher pharmaceutical tariffs. However, the fact that demand is price-insensitive and that tariffs are only likely to be phased in gradually means that any hit to GDP will be relatively small, at least in the near term. Meanwhile, plans to increase tariffs on India could shift investment toward lower-tariff neighbours, including Vietnam, Indonesia, and the Philippines.

How is global economic fracturing unfolding in Trump’s second term? Join our economists for in-person briefings on the macro and market risks around the breakdown in US-China relations and the reordering of the world economy. Register for events in Singapore (3rd Sept.) and Hong Kong (4th Sept.).

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.

By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.